Vitro Biopharma, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Vitro Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2010 to Q4 2023.
  • Vitro Biopharma, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending January 31, 2024 was -$1.2M, a 26.4% decline year-over-year.
  • Vitro Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$1.97M, a 11.2% increase from 2022.
  • Vitro Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$2.22M.
  • Vitro Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2015 was -$100K, a 16.3% increase from 2014.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$1.2M -$250K -26.4% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-14
Q4 2022 -$950K -$191K -25.2% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-14
Q4 2021 -$758K Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-14
Q4 2014 -$23.7K +$16.3K +40.8% Nov 1, 2014 Jan 31, 2015 10-Q 2015-03-24
Q4 2013 -$40K +$8.62K +17.7% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-24
Q4 2012 -$48.7K +$7.04K +12.6% Nov 1, 2012 Jan 31, 2013 10-Q 2013-03-21
Q4 2011 -$55.7K -$1.13K -2.07% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-21
Q4 2010 -$54.6K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.